Clinical trial · Observational
Evaluation of the Efficacy of Duodenal Prostheses Not Covered Over 6 Years
NCT03463668CI-TRIAL-00032046DYSPHAGIErecruitingClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
To assess the efficacy of duodenal prostheses for duodenal stenosis established for endoscopic pyloric or duodenal stenosis on dysphagia
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Digestive or Non-digestive Neoplasia Leading to Symptomatic Duodenal Stenosis | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| uncovered metal duodenal prosthesis | Device | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- symptomatic non-covered duodenal prosthesis
- description
- Any symptomatic duodenal stenosis with symptomatic duodenal duodenal prosthesis between 2010 and 2017.
- interventionNames
- Device: uncovered metal duodenal prosthesis
Primary outcomes (1)
- measure
- Dysphagia assessment
- timeFrame
- 7 years
- description
- GOOSS = Gastric Outlet Obstruction Scoring System
Secondary outcomes (5)
- measure
- Rate of complications
- timeFrame
- 7 years
- description
- Rate of complications
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Any symptomatic duodenal stenosis with symptomatic duodenal duodenal prosthesis between 2010 and 2017. Exclusion Criteria: * Benign stenosis or covered metallic duodenal prosthesis (usually indicated for benign disease)
References
Publications (4)
- BACKGROUNDFiori E, Lamazza A, Volpino P, Burza A, Paparelli C, Cavallaro G, Schillaci A, Cangemi V. Palliative management of malignant antro-pyloric strictures. Gastroenterostomy vs. endoscopic stenting. A randomized prospective trial. Anticancer Res. 2004 Jan-Feb;24(1):269-71. PMID 15015607
- BACKGROUNDJohnsson E, Thune A, Liedman B. Palliation of malignant gastroduodenal obstruction with open surgical bypass or endoscopic stenting: clinical outcome and health economic evaluation. World J Surg. 2004 Aug;28(8):812-7. doi: 10.1007/s00268-004-7329-0. Epub 2004 Aug 3. PMID 15457364
- BACKGROUNDJeurnink SM, Steyerberg EW, Hof Gv, van Eijck CH, Kuipers EJ, Siersema PD. Gastrojejunostomy versus stent placement in patients with malignant gastric outlet obstruction: a comparison in 95 patients. J Surg Oncol. 2007 Oct 1;96(5):389-96. doi: 10.1002/jso.20828. PMID 17474082
- BACKGROUNDASGE guidelines enteral stents